Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

By K. Lewis, Chien Li, M. Perrin, A. Blount, K. Kunitake, C. Donaldson, J. Vaughan, T. Reyes, J. Gulyás, W. Fischer and 4 more. Proceedings of the National Academy of Sciences of the United States of America, 2001

940 citations recorded by the source corpus.

Subfields: Behavioral Neuroscience, Physiology, Surgery

View Paper: https://www.semanticscholar.org/paper/cfdb2cf8af7d4bacf4a8248ec0087d68f5344241

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Behavioral Neuroscience

1. S. Maier
2. Abigail Zisk A.B.
3. M. D. De Bellis

In Physiology

1. Linda R. Watkins
2. S. Maier
3. Clifford J. Woolf
4. R. Ji
5. G. Moalem-Taylor
6. P. Austin
7. Alban Latremoliere

Citations in the corpus

• Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. (2005, background): “CRHR1 is widely distributed and has a relatively high affinity for CRH and low affinities for the recently discovered ligands urocortin II (UCN II, Reyes et al., 2001), and urocortin III (UCN III, Lewis et al., 2001).”
• A role for brain stress systems in addiction. (2008, neutral): “The type 2 urocortins, urocortin 2 (Reyes et al., 2001) and urocortin 3 (Lewis et al., 2001), differ from urocortin 1 and CRF in their neuroanatomical, neuropharmacological, and distribution profiles and are endogenous selective CRF2 agonists.”